Kerry Rupp will be speaking at this year’s Women’s Health Innovation Summit, the leading industry platform that connects pharma, biotech, start-ups, investors, payers, researchers, FMCGs and HCPs to accelerate innovation, investment, research, and partnerships to improve health outcomes for midlife women and beyond. Don’t miss Kerry’s panel, “Bridging the Gender Healthcare Gap through Consumer Health & Femtech”
The conference focus is on addressing the entire spectrum of this underserved area, the Women’s Health Innovation Summit stimulates discussions around the opportunities and challenges in areas relating to menopause, longevity, osteoporosis, cardiovascular health, sexual wellness, pelvic floor health, brain health, and preventative health measures.
Why Attend?
- Meet the who’s who in women’s health innovation. Our sector specific audience enables perfectly aligned networking with like-minded leaders to boost partnership opportunities.
- Our investor network is unmatched. With the biggest investment players in the women’s health and healthtech, this is where you need to be if you’re looking for funding.
- Our three-tracked agenda approach enables you to tailor your 3 days to meet your specific business needs. With the inclusion of our pre-day and multiple roundtables – every session will give you tangible, solution-led takeaways for you to implement into your strategy.
- 5 years of bringing the industry together to facilitate partnerships, investment and innovation . That’s 15 events, 3,500 delegates and over 15,000 meetings. We know what we’re delivering. Our credibility is unmatched in the space.
- Time for networking? We can’t get enough. From pre-event access to our networking app, over 10 hours of dedicated meeting time and follow up check-ins, we understand the importance of year-round communication.
Agenda and event details here: https://www.kisacoresearch.com/events/womens-health-innovation-summit-2023
Agenda Highlights
Bridging the Gender Healthcare Gap through Consumer Health & Femtech
Women are underrepresented and underserved in healthcare and yet make 80% of health purchasing decisions, resulting in a boom in femtech and women’s consumer healthcare option. But what does this mean for the broader healthcare industry and traditional healthcare players? How can retailers, e-commerce platforms and FMCGs amplify health outcomes for women? Join this discussion to unpack these questions and explore the opportunities and challenges in navigating between more traditional healthcare and the rise of consumer health.
Bethany Corbin, Founder, FemInnovation
Kerry Rupp, General Partner, True Wealth Ventures
Championing Research: Investing & Partnering in Early-Stage Discovery
Improving the benchmark for measuring disease modification and reducing the use of symptomology is imperative for addressing underserved areas in women’s health such as ovarian cancer and endometriosis. This panel discussion will deep dive into the importance of prioritizing research through a sex & gender lens to identify new molecules, exploring the challenges and opportunities in investing in early-stage research, partnering with research institutions, and considering what more can be done.
At the Heart of the Issue: Precise, Personalized and Preventative Care to Improve Women’s Cardiovascular Health
According to the American Heart Association, nearly 75% of coronary heart disease cases in women can be prevented. Identifying sex-specific
risk factors through personalized risk assessments is an important step in creating precise treatment options to improve heart health. Join this panel discussion to hear from those leading the way in reducing the number one death of women in the US.
Sustained Drug-Eluting Dosage Forms in Women’s Health: Leveraging Patient Centric Delivery
This presentation will cover VitalDose’s role in patient centric delivery within Women’s Health, exploring how using the sustained release of single or multiple drugs can relieve patient burden in chronic diseases and provide a benefit to the formulation of small molecule API to larger molecule or complex therapeutics.
Investment Strategies for Long Term Success
With more investment in women’s health than ever before, there are newer and more exciting opportunities for innovation, but it’s important to consider what types of investment will achieve the best ROI. Join this discussion to hear from a panel of experts about the investment strategies they’ve adopted, understand the innovation that’s exciting to them, and consider the key factors for long term financial success.